111 related articles for article (PubMed ID: 19111832)
1. Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice.
Schroeter MR; Humboldt T; Schäfer K; Konstantinides S
Atherosclerosis; 2009 Jul; 205(1):63-73. PubMed ID: 19111832
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
[TBL] [Abstract][Full Text] [Related]
3. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin exerts favourable effects on thrombosis and neointimal growth in a mouse model of endothelial injury.
Schäfer K; Kaiser K; Konstantinides S
Thromb Haemost; 2005 Jan; 93(1):145-52. PubMed ID: 15630505
[TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins promote endothelial progenitor cell mobilization and attenuate atherosclerotic lesions in apolipoprotein E knockout mice.
Liu Y; Hao F; Zhang H; Cao D; Lu X; Li X
Cell Physiol Biochem; 2013; 32(4):814-26. PubMed ID: 24080960
[TBL] [Abstract][Full Text] [Related]
6. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice.
Akhtar S; Gremse F; Kiessling F; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):679-86. PubMed ID: 23393393
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin inhibits MMP-2 expression and limits the progression of atherosclerosis in LDLR-deficient mice.
Guo H; Shi Y; Liu L; Sun A; Xu F; Chi J
Arch Med Res; 2009 Jul; 40(5):345-51. PubMed ID: 19766896
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin on cardiovascular morphology and function in an ApoE-knockout mouse model of atherosclerosis.
Grönros J; Wikström J; Brandt-Eliasson U; Forsberg GB; Behrendt M; Hansson GI; Gan LM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2046-53. PubMed ID: 18790840
[TBL] [Abstract][Full Text] [Related]
10. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
Schober A; Knarren S; Lietz M; Lin EA; Weber C
Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
[TBL] [Abstract][Full Text] [Related]
11. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms.
Wang JA; Chen WA; Wang Y; Zhang S; Bi H; Hong B; Luo Y; Daugherty A; Xie X
Atherosclerosis; 2011 Jul; 217(1):90-6. PubMed ID: 21481872
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.
Fadini GP; Albiero M; Boscaro E; Menegazzo L; Cabrelle A; Piliego T; Federici M; Agostini C; Avogaro A
Cell Biol Int; 2010 Jul; 34(7):709-15. PubMed ID: 20233166
[TBL] [Abstract][Full Text] [Related]
13. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.
Giunti S; Calkin AC; Forbes JM; Allen TJ; Thomas MC; Cooper ME; Jandeleit-Dahm KA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F528-35. PubMed ID: 20554645
[TBL] [Abstract][Full Text] [Related]
14. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
16. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
[TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition.
Werner N; Priller J; Laufs U; Endres M; Böhm M; Dirnagl U; Nickenig G
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1567-72. PubMed ID: 12377731
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin reduces gliosis and the accelerated weight gain observed in WT and ApoE-/- mice exposed to a high cholesterol diet.
Famer D; Crisby M
Neurosci Lett; 2007 May; 419(1):68-73. PubMed ID: 17433542
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
